Literature DB >> 7488148

Regulation of the human serotonin transporter by interleukin-1 beta.

S Ramamoorthy1, J D Ramamoorthy, P D Prasad, G K Bhat, V B Mahesh, F H Leibach, V Ganapathy.   

Abstract

The serotonin transporter expressed in brain, platelets, and placenta is a primary target for antidepressants, cocaine, and amphetamines. Here we report that interleukin-1 beta is a potent regulator of the expression of this transporter. The activity of the serotonin transporter in human JAR choriocarcinoma cells is stimulated by this cytokine and the stimulation is accompanied by an increase in the steady state levels of the transporter mRNAs and in the transporter density. The increase in mRNA levels is effectively blocked by actinomycin D. The stimulatory effect of interleukin-1 beta is not associated with any change in the cellular levels of cAMP, indicating involvement of a cAMP-independent pathway. Even though cholera toxin, which is known to increase cAMP levels, also upregulates the serotonin transporter in JAR cells, the effects of interleukin-1 beta and cholera toxin on the transporter activity are additive. This constitutes the first report on the identification of a physiologically occurring hormone/cytokine which upregulates the expression of the human serotonin transporter gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488148     DOI: 10.1006/bbrc.1995.2659

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

Review 1.  Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?

Authors:  D M Forton
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

Review 2.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 3.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

4.  The Relationship of Older Adults' Physical Pain to Depression and Post-Traumatic Stress Disorder (PTSD): A Review.

Authors:  Golnar Alamdari; Luciana Laganà
Journal:  J Geriatr Med Gerontol       Date:  2015-12-31

Review 5.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

6.  Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE.

Authors:  H H Hofstetter; R Mössner; K P Lesch; R A Linker; K V Toyka; R Gold
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

7.  Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases.

Authors:  Charles D Nichols
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-10-13

Review 8.  A dialogue between the immune system and brain, spoken in the language of serotonin.

Authors:  Nicole L Baganz; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

9.  The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes.

Authors:  Sandra Malynn; Antonio Campos-Torres; Paul Moynagh; Jana Haase
Journal:  Neurochem Res       Date:  2013-01-22       Impact factor: 3.996

10.  The 5-hydroxytryptamine transporter is functional in human coronary artery smooth muscle cells proliferation and is regulated by Interleukin-1 beta.

Authors:  Qing-Jie Wang; Dong Wang; Cheng-Chun Tang
Journal:  Int J Clin Exp Med       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.